MR
Monali Rajendra Kale
About Monali Rajendra Kale
Data last updated:
Monali Rajendra Kale is a Director at Sarvadnya Shree Infra Private Limited (since 2017) and Director at Atmatirth Pharma Private Limited (since 2024). The companies operate in Transportation. The largest current company by reported revenue is Sarvadnya Shree Infra Private Limited at ₹3.53 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Dec 2017 | 2017 | ₹3.53 Cr (FY 2023) | Active | |
| Director | 24 Jul 2024 | 2024 | Active |
Board colleagues of Monali Rajendra Kale
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shital Ganesh Mhaske | 10673654 | Sarvadnya Shree Infra Private Limited | Additional Director |
| Isha Suresh Pawar | 10718033 | Atmatirth Pharma Private Limited | Director |
| Sayali Sunil Chide | 10718034 | Atmatirth Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Monali Rajendra Kale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monali Rajendra Kale
Monali Rajendra Kale currently holds 2 directorships: Sarvadnya Shree Infra Private Limited (Director, since 08 Dec 2017, revenue ₹3.53 Cr (FY 2023)); Atmatirth Pharma Private Limited (Director, since 24 Jul 2024).
Monali Rajendra Kale was first appointed on 08 Dec 2017 as Director at Sarvadnya Shree Infra Private Limited. The most recent appointment on record is 24 Jul 2024 at Atmatirth Pharma Private Limited.
The current boards of Monali Rajendra Kale's companies include Shital Ganesh Mhaske (Sarvadnya Shree Infra Private Limited), Isha Suresh Pawar (Atmatirth Pharma Private Limited), Sayali Sunil Chide (Atmatirth Pharma Private Limited).